HanAll F&B plans rice pasta and naengmyeon expansion after filing patent for improved noodle manufacturing
EPACK Prefab Technologies expands Rajasthan manufacturing capacity with Rs 1,376cr order book, but margins remain under pressure
Read More Pharma Industry News Innovent Biologics hits 20% weight loss in Phase 3: Will mazdutide become China’s Ozempic? Mazdutide 9 mg achieves 20.08% weight loss in pivotal Chinese Phase 3 study. Learn what this means for Innovent Biologics’ NDA plans and obesity treatment. bySrinathNovember 20, 2025